India’s Covovax gets WHO’s approval

Agencies | New Delhi

The Daily Tribune – www.newsofbahrain.com

The World Health Organisation issued an emergency use listing for NVX-CoV2373 yesterday, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus to nine.

The vaccine, named CovovaxTM, is produced by the Serum Institute of India under licence from Novavax and is part of the COVAX facility portfolio.

“Even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products.

‘This listing aims to increase access particularly in lower-income countries, 41 of which have still not been able to vaccinate 10% of their populations, while 98 countries have not reached 40%.”